Australian Clinical Labs Health Care

$3.44 0.04 (1.18%)

High $3.45	Low $3.39	Trades 1,017	Turnover $1,031,103	Volume 301,613
30 June 2023 at 4:10pm

Register to track ACL and receive email alerts.

Market Cap (19-Sep) $380,974,976 (281st)	Close (30-Jun) $3.44 0 (0%)	Volume (30-Jun) 301,613	Shortsold (26-May) 15,780,800 (8.42%) (29th)
52w High $2.92	52w Low $1.83	P/E 11.49	EPS 0.14

	Subject
	ACL ACL Ann: HLS: Directors' Statement re Takeover
	1 (current) 2 3
	ACL ACL Ann: Response to Healius' Target's Statement
	ACL ACL Ann: Second Supplementary Bidder's Statement
	ACL ACL Ann: Takeover offer - receipt of Target's Statement
	ACL ACL Ann: HLS: Lodgement of Target's Statement
	ACL ACL Ann: Completion of dispatch of replacement bidder's statement
	ACL ACL Ann: Commencement of dispatch of replacement bidder's statement
	ACL ACL Ann: Notice of EGM
	ACL ACL Ann: TOV: HLS Panel Declines to Conduct Proceedings
	ACL ACL Ann: ASX announcement - Replacement Bidder's Statement
	ACL ACL Ann: Replacement Bidder's Statement
	ACL ACL Ann: First Supplementary Bidder's Statement
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: TOV: HLS Panel Receives Application
	ACL ACL Ann: Update - Dividend/Distribution - ACL
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Suspension of DRP
	ACL ACL Ann: HLS: Directors' Statement re Takeover
	ACL ACL Ann: Proposed issue of securities - ACL
	ACL ACL Ann: Becoming a substantial holder for HLS
	ACL ACL Ann: People to whom information is to be sent
	ACL ACL Ann: HLS: Off-market takeover bid from ACL
	ACL ACL Ann: Investor Webinar - Takeover Offer for Healius
	ACL ACL Ann: Investor Presentation - Takeover Offer for Healius
	ACL ACL Ann: Bidder's Statement in relation to Takeover Offer for Healius
	ACL ACL Ann: Takeover Offer for Healius Limited
	ACL ACL Ann: Notification regarding unquoted securities - ACL
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Notification regarding unquoted securities - ACL
	ACL ACL Ann: Notification of cessation of securities - ACL
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Dividend/Distribution - ACL
	ACL ACL Ann: 1H23 results investor presentation
	ACL ACL Ann: Appendix 4D and 1H23 financial reports
	ACL ACL Ann: 1H23 Financial Results release details
	ACL ACL Ann: Release of Shares from Voluntary Escrow
	ACL ACL Ann: Medlab Cyber Incident Update
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Medlab Pathology Cyber Incident
	ACL ACL Ann: 2022 AGM - Results of Meeting
	ACL ACL Ann: 2022 AGM - addresses to shareholders
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Director Appointment/Resignation
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Ceasing to be a substantial shareholder
	ACL ACL Ann: 2022 Annual Report and Corporate Governance Statement
	ACL ACL Ann: Appendix 4G

Register to track ACL and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$2.50	225,096	-0.04 (1.57%)
12-Sep	$2.54	801,104	+0.05 (2.01%)
11-Sep	$2.49	523,465	-0.11 (4.23%)
05-Sep	$2.60	345,815	-0.03 (1.14%)
04-Sep	$2.63	800,632	+0.02 (0.77%)
03-Sep	$2.61	517,066	-0.24 (8.42%)
29-Aug	$2.85	1,474,174	+0.05 (1.79%)
28-Aug	$2.80	1,322,727	+0.29 (11.55%)
22-Aug	$2.51	2,403,463	-0.01 (0.40%)
21-Aug	$2.52	3,147,891	-0.18 (6.67%)
15-Aug	$2.70	445,630	-0.01 (0.37%)
14-Aug	$2.71	314,412	-0.12 (4.24%)
07-Aug	$2.83	307,510	+0.07 (2.54%)
31-Jul	$2.76	584,437	-0.04 (1.43%)
30-Jul	$2.80	461,954	-0.02 (0.71%)
5 up, 10 down, and 0 flat days